The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PD-L1 expression in Epstein-Barr virus-infected gastric cancers.
 
Sarah Derks
No Relationships to Disclose
 
Xiaoyun Liao
No Relationships to Disclose
 
Xinsen Xu
No Relationships to Disclose
 
M. Constanza Camargo
No Relationships to Disclose
 
Anna M Chiaravalli
No Relationships to Disclose
 
Enrico Solcia
No Relationships to Disclose
 
Tania Fleitas
No Relationships to Disclose
 
Gordon J. Freeman
Stock and Other Ownership Interests - Novartis; Novartis (I)
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Novartis; Novartis (I); Roche/Genentech; Surface Oncology (I)
Patents, Royalties, Other Intellectual Property - Amplimmune/Astrazeneca; Boehringer Ingelheim; Bristol-Myers Squibb/Medarex; EMD Serono; Merck; Novartis; Novartis (I); Pfizer (I); Roche/Genentech; Roche/Genentech (I)
 
Scott J. Rodig
Honoraria - Bristol-Myers Squibb; Perkin Elmer
Consulting or Advisory Role - AstraZeneca; Perkin Elmer
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Patent pending for use of Anti-galectin1 antibodies for diagnostic use.
Travel, Accommodations, Expenses - Roche
 
Charles S. Rabkin
No Relationships to Disclose
 
Adam Joel Bass
Leadership - Strand Life Sciences
Research Funding - Onkaido Therapeutics; Sanofi